Researchers presented interim findings from the SPARTAN trial at the National Kidney Foundation Spring Clinical Meetings. SPARTAN is a phase 2, open-label ... hypotension and half of participants ...

The trial found it could reduce kidney disease risk ... company has also filed for a label expansion in the US, and a decision is expected in the first half of 2025.

Data from the study showed the drug cuts the risk of kidney disease ... has also filed for a label expansion in the U.S., and a decision is expected in the first half of 2025.

For their open-label randomized trial ... Mean left ventricular ejection fraction was 40%; about half of the cohort had reduced ejection fraction, the remainder split between mildly reduced ...

Before eating bran cereal, oatmeal, or granola, check the nutritional label to determine the amount ... which is nearly half of the daily recommended amount for someone with chronic kidney disease who ...

NEW YORK – Swedish diagnostics firm Elypta shared promising results this week from a clinical trial of its noninvasive metabolite-based test intended to aid clinicians in monitoring kidney cancer ...

"Despite the "egg white" and "turkey sausage" label, the ingredients still include ... If you have a medical history of cardiovascular disease or kidney disease, you have already eaten almost half (40 ...

While nearly half of Americans don't get enough magnesium through ... Transdermal magnesium for the treatment of peripheral neuropathy in chronic kidney disease: a single-arm, open-label pilot study.

Eleanor Rivera receives funding from the National Institutes of Health. She is affiliated with the National Kidney Foundation and the Department of Veterans Affairs. For a disease afflicting 35.5 ...

Today, approximately half of Black Americans carry at least one APOL-1 risk allele, with one in ten carrying two copies – the configuration associated with highest kidney disease risk.

Real-world data supports tolvaptan use to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).